Kodiak Sciences Inc. (KOD)
NASDAQ: KOD · Real-Time Price · USD
36.23
+1.13 (3.23%)
May 28, 2026, 1:03 PM EDT - Market open
Kodiak Sciences Employees
Kodiak Sciences had 130 employees as of March 31, 2026. The number of employees increased by 17 or 15.04% compared to the same quarter last year.
Employees
130
Change
17
Growth
15.04%
Revenue / Employee
n/a
Profits / Employee
-$1,774,338
Market Cap
2.26B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 130 | 17 | 15.04% |
| Dec 31, 2025 | 124 | 15 | 13.76% |
| Sep 30, 2025 | 123 | 15 | 13.89% |
| Jun 30, 2025 | 121 | 10 | 9.01% |
| Mar 31, 2025 | 113 | 6 | 5.61% |
| Dec 31, 2024 | 109 | -2 | -1.80% |
| Sep 30, 2024 | 108 | -8 | -6.90% |
| Jun 30, 2024 | 111 | -7 | -5.93% |
| Mar 31, 2024 | 107 | -8 | -6.96% |
| Dec 31, 2023 | 111 | -1 | -0.89% |
| Sep 30, 2023 | 116 | 11 | 10.48% |
| Jun 30, 2023 | 118 | 17 | 16.83% |
| Mar 31, 2023 | 115 | 14 | 13.86% |
| Dec 31, 2022 | 112 | 19 | 20.43% |
| Sep 30, 2022 | 105 | 20 | 23.53% |
| Jun 30, 2022 | 101 | 25 | 32.89% |
| Mar 31, 2022 | 101 | 24 | 31.17% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Zai Lab | 1,784 |
| Ultragenyx Pharmaceutical | 1,371 |
| Vera Therapeutics | 339 |
| Immunome | 206 |
| Celldex Therapeutics | 198 |
| Pharvaris | 129 |
| Definium Therapeutics | 106 |
| Nanobiotix | 100 |
KOD News
- 17 days ago - Kodiak Sciences upgraded to Buy from Neutral at Chardan - TheFly
- 20 days ago - Kodiak Sciences reports Q1 EPS (94c), consensus ($1.01) - TheFly
- 20 days ago - Kodiak Sciences Announces Recent Business Highlights and First Quarter 2026 Financial Results - PRNewsWire
- 20 days ago - Kodiak Sciences Earnings release: Q1 2026 - Filings
- 20 days ago - Kodiak Sciences Quarterly report: Q1 2026 - Filings
- 27 days ago - Kodiak Sciences to Present Pipeline Advances and KSI-101 Clinical Data, Including Results from a MESI Cohort in a Tertiary Care Uveitis Practice, at Upcoming Scientific Conferences - PRNewsWire
- 5 weeks ago - Kodiak Sciences Proxy statement: Proxy filing - Filings
- 5 weeks ago - Kodiak Sciences Proxy statement: Proxy filing - Filings